Inogen Inc Common Stock
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN Overview
Sector |
Health Care |
Industry |
Industrial Specialties |
Previous Close |
$8.7500 |
Previous Close Volume |
283660 |
Latest News
- Inogen Announces Third Quarter 2024 Financial Results 07 Nov 2024 16:17:51
- Inogen to Present at Upcoming Investor Conferences 04 Nov 2024 08:32:56
- Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 17 Oct 2024 08:55:55
- Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC 08 Oct 2024 08:56:01
- Inogen Appoints Eric Pauls as Vice President of Sales, North America 05 Sep 2024 08:32:38
- Inogen Announces Second Quarter 2024 Financial Results 06 Aug 2024 16:26:15
- Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024 16 Jul 2024 08:41:19
- Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development 03 Jul 2024 16:26:26
- Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio 03 Jun 2024 16:26:29
- Inogen Announces First Quarter 2024 Financial Results 07 May 2024 16:11:42
- Inogen to Report First Quarter 2024 Financial Results on May 7, 2024 10 Apr 2024 08:41:37
- Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference 25 Mar 2024 08:42:00
- Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 07 Mar 2024 16:11:50
- Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results 27 Feb 2024 16:26:56
- Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 30 Jan 2024 16:11:44
- Inogen Names Michael Bourque as New Chief Financial Officer 24 Jan 2024 16:11:59